Genentech to Invest $750M in Manufacturing Facility in Hillsboro, Oregon
HILLSBORO, ORE. — Genentech, a member of the Roche Group, plans to invest $750 million in a new device fill-finish manufacturing facility at its 75-acre campus in Hillsboro. The development will bring new end-to-end device filling capabilities to the site and expand Genentech’s capacity to support its future…
Published by REBusiness Online. Global Real Estate Intelligence links to the original source and credits the publisher; all rights remain with them.
Provenance
- Publisher
- REBusiness Online
- Obtained from
- REBusiness Online
- Published
- Aug 24, 2026
- Last updated
- Aug 24, 2026 (today)
Global Real Estate Intelligence records where every item came from and when we last refreshed it. Where a field reads Unknown we could not establish it, and we do not guess.





